Katarina Le Blanc

49.3k total citations · 14 hit papers
149 papers, 37.4k citations indexed

About

Katarina Le Blanc is a scholar working on Genetics, Hematology and Surgery. According to data from OpenAlex, Katarina Le Blanc has authored 149 papers receiving a total of 37.4k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Genetics, 52 papers in Hematology and 43 papers in Surgery. Recurrent topics in Katarina Le Blanc's work include Mesenchymal stem cell research (100 papers), Hematopoietic Stem Cell Transplantation (47 papers) and Tissue Engineering and Regenerative Medicine (30 papers). Katarina Le Blanc is often cited by papers focused on Mesenchymal stem cell research (100 papers), Hematopoietic Stem Cell Transplantation (47 papers) and Tissue Engineering and Regenerative Medicine (30 papers). Katarina Le Blanc collaborates with scholars based in Sweden, United States and Italy. Katarina Le Blanc's co-authors include Olle Ringdén, Armand Keating, Massimo Dominici, Ineke Slaper‐Cortenbach, Ingo Mueller, R. Deans, Edwin M. Horwitz, Darwin J. Prockop, F. Marini and Diane S. Krause and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Katarina Le Blanc

149 papers receiving 36.5k citations

Hit Papers

Minimal criteria for defining multipotent mesenchymal str... 2003 2026 2010 2018 2006 2004 2008 2005 2015 4.0k 8.0k 12.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
    2006 13.5k citations Katarina Le Blanc, Edwin M. Horwitz et al. Cytotherapy profile →
  2. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
    2004 2.1k citations Katarina Le Blanc, Berit Sundberg et al. profile →
  3. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
    2008 2.0k citations Katarina Le Blanc, Francesco Frassoni et al. profile →
  4. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement
    2005 1.5k citations Katarina Le Blanc et al. Cytotherapy profile →
  5. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting
    2015 1.3k citations Imre Mäger, Nina Heldring et al. profile →
  6. HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells
    2003 1.3k citations Katarina Le Blanc, Charlotte Tammik et al. Experimental Hematology profile →
  7. Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility Complex
    2003 1.1k citations Katarina Le Blanc, Berit Sundberg et al. profile →
  8. Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease
    2006 893 citations Olle Ringdén, Berit Sundberg et al. profile →
  9. Multipotent mesenchymal stromal cells and the innate immune system
    2012 768 citations Katarina Le Blanc, Dimitrios Mougiakakos profile →
  10. Immunomodulation by mesenchymal stem cells and clinical experience
    2007 557 citations Katarina Le Blanc, Olle Ringdén profile →
  11. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells
    2003 519 citations Olle Ringdén, Berit Sundberg et al. profile →
  12. Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans Indicates Limited Long-Term Engraftment and No Ectopic Tissue Formation
    2012 425 citations Berit Sundberg, Olle Ringdén et al. profile →
  13. Mesenchymal stromal cells: Putative microenvironmental modulators become cell therapy
    2021 173 citations Mauro Krampera, Katarina Le Blanc profile →
  14. ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cells
    2025 17 citations Katarina Le Blanc, Francesco Dazzi et al. Cytotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katarina Le Blanc Sweden 65 26.5k 13.5k 10.9k 4.8k 4.8k 149 37.4k
Armand Keating Canada 63 16.0k 0.6× 8.1k 0.6× 8.5k 0.8× 5.3k 1.1× 5.3k 1.1× 342 29.8k
Pamela Gehron Robey United States 89 18.6k 0.7× 9.3k 0.7× 17.9k 1.6× 7.4k 1.6× 2.6k 0.6× 298 47.6k
Diane S. Krause United States 49 14.1k 0.5× 9.0k 0.7× 8.9k 0.8× 2.7k 0.6× 2.1k 0.4× 150 24.9k
Mark F. Pittenger United States 30 19.6k 0.7× 11.6k 0.9× 11.6k 1.1× 3.0k 0.6× 1.5k 0.3× 46 32.3k
Edwin M. Horwitz United States 49 14.9k 0.6× 7.9k 0.6× 6.8k 0.6× 3.3k 0.7× 2.2k 0.5× 163 22.8k
Massimo Dominici Italy 50 14.9k 0.6× 8.1k 0.6× 7.7k 0.7× 4.0k 0.8× 1.5k 0.3× 282 24.3k
Stan Gronthos Australia 76 19.5k 0.7× 8.8k 0.7× 12.3k 1.1× 2.9k 0.6× 1.3k 0.3× 235 33.2k
Willem E. Fibbe Netherlands 59 11.1k 0.4× 6.2k 0.5× 4.9k 0.4× 3.6k 0.8× 3.9k 0.8× 215 19.4k
Mark A. Moorman United States 22 11.4k 0.4× 7.7k 0.6× 7.4k 0.7× 2.0k 0.4× 1.0k 0.2× 29 20.9k
Joseph D. Mosca United States 17 12.5k 0.5× 6.6k 0.5× 6.7k 0.6× 2.1k 0.4× 1.2k 0.2× 28 20.0k

Countries citing papers authored by Katarina Le Blanc

Since Specialization
Citations

This map shows the geographic impact of Katarina Le Blanc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katarina Le Blanc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katarina Le Blanc more than expected).

Fields of papers citing papers by Katarina Le Blanc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katarina Le Blanc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katarina Le Blanc. The network helps show where Katarina Le Blanc may publish in the future.

Co-authorship network of co-authors of Katarina Le Blanc

This figure shows the co-authorship network connecting the top 25 collaborators of Katarina Le Blanc. A scholar is included among the top collaborators of Katarina Le Blanc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katarina Le Blanc. Katarina Le Blanc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davies, Lindsay C., Lucie Biard, Damián García‐Olmo, et al.. (2025). Defining minimal criteria for peer-reviewed reporting of mesenchymal stromal cell clinical trials for autoimmune diseases. Cytotherapy. 27(11). 1326–1337. 1 indexed citations
2.
3.
4.
Häbel, Henrike, Karin Garming Legert, Robert Heymann, et al.. (2022). Immunohistopathology of oral mucosal chronic graft‐versus‐host disease severity and duration. Oral Diseases. 29(8). 3346–3359. 2 indexed citations
5.
Hertegård, Stellan, et al.. (2019). Hyaluronan Hydrogels for the Local Delivery of Mesenchymal Stromal Cells to the Injured Vocal Fold. Stem Cells and Development. 28(17). 1177–1190. 10 indexed citations
6.
Martín, Iván, et al.. (2019). Challenges for mesenchymal stromal cell therapies. Science Translational Medicine. 11(480). 125 indexed citations
7.
Blanc, Katarina Le & Lindsay C. Davies. (2018). MSCs—cells with many sides. Cytotherapy. 20(3). 273–278. 82 indexed citations
8.
Mao, Yumeng, Nina Eißler, Katarina Le Blanc, et al.. (2016). Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma. Clinical Cancer Research. 22(15). 3849–3859. 107 indexed citations
9.
Qian, Hong, et al.. (2015). Amniotic Fluid—A Source for Clinical Therapeutics in the Newborn?. Stem Cells and Development. 24(12). 1405–1414. 15 indexed citations
10.
Heldring, Nina, Imre Mäger, Matthew J. A. Wood, Katarina Le Blanc, & Samir EL Andaloussi. (2015). Therapeutic Potential of Multipotent Mesenchymal Stromal Cells and Their Extracellular Vesicles. Human Gene Therapy. 26(8). 506–517. 148 indexed citations
11.
Erben, Reinhold G., Beatriz Silva Lima, Ilona Reischl, et al.. (2014). White Paper on How to Go Forward with Cell-Based Advanced Therapies in Europe. Tissue Engineering Part A. 20(19-20). 2549–2554. 22 indexed citations
12.
Mougiakakos, Dimitrios, Maciej Machaczka, Regina Jitschin, et al.. (2012). Treatment of Familial Hemophagocytic Lymphohistiocytosis with Third-Party Mesenchymal Stromal Cells. Stem Cells and Development. 21(17). 3147–3151. 15 indexed citations
13.
Davies, Lindsay C., Helena Lönnies, Matthew Locke, et al.. (2011). Oral Mucosal Progenitor Cells Are Potently Immunosuppressive in a Dose-Independent Manner. Stem Cells and Development. 21(9). 1478–1487. 32 indexed citations
14.
Ringdén, Olle & Katarina Le Blanc. (2011). Mesenchymal stem cells for treatment of acute and chronic graft-versus-host disease, tissue toxicity and hemorrhages. Best Practice & Research Clinical Haematology. 24(1). 65–72. 71 indexed citations
15.
Ball, L.M., Maria Ester Bernardo, Maarten J. D. van Tol, et al.. (2011). Mesenchymal stromal cells are highly effective in steroid-refractory, grade III-IV acute graft-versus-host disease in children. Bone Marrow Transplantation. 46. 1 indexed citations
16.
Sundin, Mikael, Anna Lindblom, Claes Örvell, et al.. (2008). Persistence of Human Parvovirus B19 in Multipotent Mesenchymal Stromal Cells Expressing the Erythrocyte P Antigen: Implications for Transplantation. Biology of Blood and Marrow Transplantation. 14(10). 1172–1179. 29 indexed citations
17.
Ringdén, Olle, Katarina Le Blanc, & Mats Remberger. (2005). Granulocyte and granulocyte-macrophage colony-stimulating factors in allografts: Uses, misuses, misconceptions, and future applications. Experimental Hematology. 33(5). 505–512. 16 indexed citations
18.
Götherström, Cecilia, Olle Ringdén, Charlotte Tammik, et al.. (2004). Immunologic properties of human fetal mesenchymal stem cells. American Journal of Obstetrics and Gynecology. 190(1). 239–245. 190 indexed citations
19.
Grinnemo, Karl‐Henrik, Å Månsson, Göran Dellgren, et al.. (2004). Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium. Journal of Thoracic and Cardiovascular Surgery. 127(5). 1293–1300. 236 indexed citations
20.
Blanc, Katarina Le, Cecilia Götherström, Olle Ringdén, et al.. (2004). Mesenchymal Stem Cell Engraftment in Bone Following In Utero Transplantation in a Patient with Severe Osteogenesis Imperfecta.. Blood. 104(11). 505–505. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Armand Keating Breakdown of academic impact, for papers by Pamela Gehron Robey Breakdown of academic impact, for papers by Diane S. Krause Breakdown of academic impact, for papers by Mark F. Pittenger Breakdown of academic impact, for papers by Edwin M. Horwitz Breakdown of academic impact, for papers by Massimo Dominici Breakdown of academic impact, for papers by Stan Gronthos Breakdown of academic impact, for papers by Willem E. Fibbe Breakdown of academic impact, for papers by Mark A. Moorman Breakdown of academic impact, for papers by Joseph D. Mosca
Rankless by CCL
2026